Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Teva Pharmaceutical Industries Limited (“Teva” or the “Company”) (NYSE: TEVA) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at brian@lundinlawpc.com.

On November 3, 2016, Bloomberg News reported that the Justice Department is conducting an antitrust investigation of over a dozen companies, including Teva, to determine whether they unlawfully colluded with each other to fix generic drug prices.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Lundin Law PCBrian Lundin, Esq.Telephone: 888-713-1033Facsimile: 888-713-1125brian@lundinlawpc.comhttp://lundinlawpc.com/

Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Teva Pharmaceutical Indu...
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Teva Pharmaceutical Indu...